Satoshi Minoshima

Radiology

1138 E Wilmington Ave
Salt Lake City, UT 84106

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 90 publications

FOLR1-targeted actinium-225-based alpha-particle therapy eliminates ovarian cancer.

FOLR1-targeted actinium-225-based alpha-particle therapy eliminates ovarian cancer.

Journal: Science advances

Published: June 24, 2026

Pearls and Pitfalls of 18F-FDG PET/CT for Suspected Alzheimer's Disease in Patient with Down Syndrome.

Pearls and Pitfalls of 18F-FDG PET/CT for Suspected Alzheimer's Disease in Patient with Down Syndrome.

Journal: Molecular imaging and radionuclide therapy

Published: June 23, 2026

FDG-PET in Movement Disorders and Parkinsonian Syndromes.

FDG-PET in Movement Disorders and Parkinsonian Syndromes.

Journal: PET clinics

Published: June 18, 2026

FOLR1-targeted Actinium-225-based Alpha-particle Therapy Eliminates Ovarian Cancer.

FOLR1-targeted Actinium-225-based Alpha-particle Therapy Eliminates Ovarian Cancer.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Real-world experience with lecanemab therapy for Alzheimer's disease in the Intermountain West.

Real-world experience with lecanemab therapy for Alzheimer's disease in the Intermountain West.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: October 07, 2025

Corrigendum to '18F-FDG PET for Dementia Evaluation: Co-pathologies, New Diseases, and Its Roles in The Era of Anti-Amyloid Treatment' [Seminar in Nuclear Medicine volume 55 (2025):526 -537/Article number YSNUC_51208].

Corrigendum to '18F-FDG PET for Dementia Evaluation: Co-pathologies, New Diseases, and Its Roles in The Era of Anti-Amyloid Treatment' [Seminar in Nuclear Medicine volume 55 (2025):526 -537/Article number YSNUC_51208].

Journal: Seminars in nuclear medicine

Published: September 26, 2025

Copathologies of Limbic-Predominant Age-Related TDP-43 Encephalopathy and Alzheimer Disease: [18F]FDG PET Statistical Mapping and Quantitative MRI Volumetry.

Copathologies of Limbic-Predominant Age-Related TDP-43 Encephalopathy and Alzheimer Disease: [18F]FDG PET Statistical Mapping and Quantitative MRI Volumetry.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: August 16, 2025

18F-FDG PET for Dementia Evaluation: Co-pathologies, New Diseases, and Its Roles in the Era of Antiamyloid Treatment.

18F-FDG PET for Dementia Evaluation: Co-pathologies, New Diseases, and Its Roles in the Era of Antiamyloid Treatment.

Journal: Seminars in nuclear medicine

Published: April 20, 2025

Developmental Venous Anomaly: Its Impact on Brain Parenchymal Function as Revealed by FDG PET.

Developmental Venous Anomaly: Its Impact on Brain Parenchymal Function as Revealed by FDG PET.

Journal: Clinical nuclear medicine

Published: January 14, 2025

From Genome to Phenome: Opportunities and Challenges of Molecular Imaging.

From Genome to Phenome: Opportunities and Challenges of Molecular Imaging.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: January 07, 2025

Brain FDG PET Findings Mimicking Limbic-predominant Age-related TDP-43 Encephalopathy.

Brain FDG PET Findings Mimicking Limbic-predominant Age-related TDP-43 Encephalopathy.

Journal: Clinical nuclear medicine

Published: January 03, 2025

New landscape of the diagnosis of Alzheimer's disease.

New landscape of the diagnosis of Alzheimer's disease.

Journal: Lancet (London, England)

Published: December 15, 2024

Showing 1-12 of 90

Last Updated: 09/26/2026